A STRATEGY FOR DEVELOPING NEW TREATMENT PARADIGMS FOR NEUROPSYCHIATRIC AND NEUROCOGNITIVE SYMPTOMS IN ALZHEIMER'S DISEASE

• Auteurs principaux: Hugo eGeerts (Auteur), Athan eSpiros (Auteur), Patrick eRoberts (Auteur), Robert eCarr (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2013-04-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Successful disease-modifying drug development for Alzheimer's disease has hit a roadblock with the recent failures of amyloid-based therapies, highlighting the translational disconnect between preclinical animal models and clinical outcome. Although disease-modifying therapies are the Holy Grai...